Antiviral pyrazolopyridine compounds

Details Antiviral pyrazolopyridine compounds Antiviral pyrazolopyridine compounds

2006-11-28

2006-11-28

Rao, Deepak (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S252180, C514S274000, C514S275000, C544S122000, C544S315000, C544S331000

Reexamination Certificate

active

07141569

ABSTRACT:
The present invention provides compounds of formula (I):pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents.

REFERENCES:
patent: 4576952 (1986-03-01), Hurst et al.
patent: 4621089 (1986-11-01), Ward et al.
patent: 4670432 (1987-06-01), Ward et al.
patent: 4985444 (1991-01-01), Shiokawa et al.
patent: 5155114 (1992-10-01), Shiokawa et al.
patent: 5204346 (1993-04-01), Shiokawa et al.
patent: 5234930 (1993-08-01), Shiokawa
patent: 5296490 (1994-03-01), Shiokawa et al.
patent: 5300478 (1994-04-01), Michaely et al.
patent: 5498774 (1996-03-01), Mitsudera et al.
patent: 5552422 (1996-09-01), Gauthier et al.
patent: 5700816 (1997-12-01), Isakson et al.
patent: 5773530 (1998-06-01), Akahane et al.
patent: 5990148 (1999-11-01), Isakson et al.
patent: 6136839 (2000-10-01), Isakson et al.
patent: 6207675 (2001-03-01), Carry et al.
patent: 6919352 (2005-07-01), Chamberlain et al.
patent: 6962914 (2005-11-01), Gudmundsson et al.
patent: 2004/0053942 (2004-03-01), Alberti et al.
patent: 0 364 204 (1989-10-01), None
patent: 0 404 190 (1990-06-01), None
patent: 0 404 190 (1990-06-01), None
patent: 0 379 979 (1990-08-01), None
patent: 0 467 248 (1991-07-01), None
patent: 0 497 258 (1992-01-01), None
patent: 2 757 059 (1998-06-01), None
patent: WO 91 00092 (1991-01-01), None
patent: WO 91 19497 (1991-12-01), None
patent: WO 95 00501 (1995-01-01), None
patent: WO 96 06840 (1996-03-01), None
patent: WO 96 21667 (1996-07-01), None
patent: WO 96 31509 (1996-10-01), None
patent: WO 96 41625 (1996-12-01), None
patent: WO 96 41626 (1996-12-01), None
patent: WO 96 41645 (1996-12-01), None
patent: WO 98 56377 (1998-12-01), None
patent: WO 99 12930 (1999-03-01), None
patent: WO 99/58523 (1999-11-01), None
patent: WO 99/59585 (1999-11-01), None
patent: WO 99 64419 (1999-12-01), None
patent: WO 00/26216 (2000-05-01), None
patent: WO 00/52008 (2000-09-01), None
patent: WO 01/00615 (2001-01-01), None
patent: WO 01 14375 (2001-03-01), None
patent: WO 02/16359 (2002-02-01), None
patent: WO 02 16359 (2002-02-01), None
patent: WO 02 18382 (2002-03-01), None
patent: WO 02/18382 (2002-03-01), None
patent: WO 02 48147 (2002-06-01), None
patent: WO 02/048148 (2002-06-01), None
patent: WO 02 066481 (2002-08-01), None
patent: WO 02/066481 (2002-08-01), None
patent: WO 03/00682 (2003-01-01), None
Bosseray et al., PubMed Abstract (Pathol Biol (Paris) 50(8):483-92), Oct. 2002.
Razonable et al., PubMed Abstract (Herpes 10(3):60-5), Dec. 2003.
Vippagunta et al., Crystalline Solids, Advanced Drug Delivery Reviews 48:3-26, 2001.
West, Solid Solutions, Solid State Chemistry and Its Applications, pp. 365, 1988.
Douglas, Jr. Introduction to Viral Diseases, Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 1739-1747, 1996.
Vane, J. et al. “Towards a Better Aspirin.” Nature, vol. 367, Jan. 20, 1994, pp. 215-216.
Carter, J. et al. “Recently Reported Inhibitors of Cyclooxygenase-2.” Exp. Opin. Ther. Patents (1998), 8(1), pp. 21-29.
Talley, JJ., “Review Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis, Selective Inhibitors of Cyclooxygenase-2.” Exp. Opin. Ther. Patents (1997) 7(1), pp. 55-62.
Roy, P., “A New Series of Selective Cox-2 Inhibitors: 5,6-Diarylthiazolo [3,2-b][1,22,4] Triazoles,”Bioorganiz & Med. Chem. Ltrs., vol. 7, No. 1, 1997, pp. 57-62.
Therien, Michael, Synthesis and Biological Evaluation of 5, 6-Diarylimidazo[2.1-b]Thiazole As Selective Cox-2 Inhibitors,Bioorganic & Med. Chem. Ltrs., vol. 7, No. 1, 1997, pp. 47-52.
Akahane, Atsushi, “Discovery of 6-Oxo-3-(2-Phenlypyrazolo[1,5-a]pyridin-3-yl)-1(6H)-pyridazinebutanoic Acid (FR 838): A Novel Xanthine Adenosine A1Receptor Antagonist with Potent Diuretic Activity,”Journal of Medicinal Chemistry, vol. 42, No. 5, 1999, pp. 779-783.
Talley, John J., 5 Selective Inhibitors of Cyclooxygenase-2 (COX-2)Progress in Medicinal Chemistry, vol. 36, (1999): pp. 201-234.
Boehm, J.C., et al. “1-Substituted 4-Aryl-5-pyridinylimidazoles: A New Class of Cytokine Suppressive Drugs with Low 5-Lipoxygenase and Cyclooxygenase Inhibitory Potency.” J. Med. Chem. 1996, 39, pp. 3929-3937.
Hanson, G.J., et al. “Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis, Inhibitors of p. 38 kinase.” Expert Opinion Ther. Patents, 1997, 7(7):729-733.
Roizman et al., “The Family Herpesviridae: A Brief Introduction,”Field Virologyvol. 2, 4thEdition, pp. 2381-2397, 2001.

Affiliated with

Also associated with

Rating

Antiviral pyrazolopyridine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiviral pyrazolopyridine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral pyrazolopyridine compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3631888